About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Clinical Updates & Treatment Advances in Metastatic Cervical Cancer from SGO
Clinical Updates & Treatment Advances in Metastatic Cervical Cancer from SGO
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
B
Treating Metastatic/Recurrent Cervical Cancer With Tisotumab Vedotin
By
Brian Slomovitz
597 views
April 4, 2022
0 Comments
Login to view comments.
Click here to Login
Clinical Updates & Treatment Advances in Metastatic Cervical Cancer from SGO
07:22
SGO 2022 Conference Coverage on VuMedi
SGO 2022 on Shared Decision Making in Frontline Maintenance Therapy …
Feat.
A. Haggerty
10:41
SGO 2022 Conference Coverage on VuMedi
SGO 2022: Development of an Interactive Precision Medicine Dashboard…
Feat.
A. Haggerty
10:16
Brian Slomovitz
Treating Metastatic/Recurrent Cervical Cancer With Tisotumab Vedotin
11:28
SGO 2022 Conference Coverage on VuMedi
SGO 2022 on Clinical Outcomes of Ovarian Cancer Patients Treated Wit…
Feat.
I. Winer
13:30
SGO 2022 Conference Coverage on VuMedi
SGO 2022 on a Randomized Phase 3 Trial of IP vs. IV Carboplatin With…
Feat.
K. Fujiwara
23:34
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2022
Updates in Gynecologic Oncology: Better Strategy in 2022
Feat.
G. Konecny
07:31
SGO 2022 Conference Coverage on VuMedi
SGO 2022 on Pembrolizumab for Persistent, Recurrent, or Metastatic C…
Feat.
D. Barrington
08:27
UCLA Health
Recurrent Cervical Cancer: Updates on Management
Feat.
R. Salani
05:21
SGO 2022 Conference Coverage on VuMedi
SGO 2022 Phase II Trial of Maintenance Niraparib in Stage III/IV or …
Feat.
M. Frimer
08:08
SGO 2022 Conference Coverage on VuMedi
SGO 2022 Final OS Results From SOLO3: Phase III Trial Assessing Olap…
Feat.
R. Penson
11:09
Krishnansu Tewari
Treating Metastatic or Recurrent Cervical Cancer With an Antibody-Dr…
07:50
Nebraska Oncology Society
Nebraska Oncology Society Advances in Cervical Cancer
Feat.
L. Coffman
09:01
Yale Cancer Center
Radiotherapy Applications for Gynecological Cancers
Feat.
D. Addeo
26:19
Total Health
Cervical Cancer: Key Data Review
Feat.
C. Kyi
10:47
Jyoti Mayadev
Advances in Immunotherapy for Cervical Cancer: Recent Developments a…
06:44
Cedars Sinai
Goals of Care and QoL in Patients With Metastatic Cervical Cancer: W…
Feat.
B. Rimel
